Acasti Pharma, Inc.

Q2 2024 13F Holders

Symbol
ACST
CUSIP
00430K865
Type
Equity
Class
CL A
Num filings
15
Total reported value, excl. options
$6.31 M
Manager Report Date Value ($000) Shares Option Type